Small Business Resources, Business Advice and Forms from AllBusiness.com
 

Cankermelts-GX Awarded National Health & Wellness Seal of Approval; Approval Rating of 79%...

BELLEVUE, Wash. -- Orahealth Corporation announced today that Today's Health & Wellness has given Cankermelts-GX the Tested and Recommended Seal of Approval of the National Health & Wellness Club. The Seal of Approval was awarded after Cankermelts-GX received an approval rating of

79% in testing by National Health & Wellness Club members. The effectiveness and satisfaction with Cankermelts-GX was based upon the experience of 113 Health and Wellness club members who used Cankermelts-GX on their sores. Cankermelts-GX is a unique canker sore treatment that delivers the natural anti-inflammatory Glycyrrhiza extract (licorice root) in a patented, time-released oral medicated disc.

"This award is another example of an independent evaluation showing how satisfied canker sore sufferers are with Cankermelts-GX in relieving their pain and speeding the healing of their canker sores," said company President, Jeff Haley. These results are consistent with the NoCankerSores.com website review of canker sore treatments that gave Cankermelts-GX its highest and best rating. Cankermelts-GX also is consistently given a high ranking by consumers on Amazon.com.

The success reported by users of Cankermelts-GX is consistent with scientific research done on the product. In April, 2005, a leading journal of oral medicine (OOOOE) published the results of a study which concluded that the use of Cankermelts-GX "for at least 16 hours per day shortens healing time to 1 - 3 days and relieves pain while the disc is in place."

Cankermelts-GX is now sold at over 1,800 pharmacies and can also be purchased from various internet sites. All pharmacies in the United States can order Cankermelts-GX from their wholesale distributors.

About Orahealth USA, Inc.

Orahealth Corporation is a privately-held OTC medication company that specializes in treating diseases of the mouth and is committed to providing the most effective treatments for the more than 50 million canker sore sufferers nationwide. Orahealth was founded in 2002 by Jeff Haley, after researching, developing and patenting Cankermelts-GX. A center of innovation for the treatment of canker sores and other oral health problems, Orahealth is based in Bellevue, Washington.

In addition, make sure to read these articles:

  • Licorice Heals Canker Sores When Applied by...
  • BELLEVUE, Wash. -- A study showing the effectiveness of a patented medicating disc using Licorice root (Glycyrrhiza) in healing and relieving the pain of ......
  • ICOS Corporation Reports Results for First Quarter...
  • Business Editors BOTHELL, Wash.--(BUSINESS WIRE)--May 3, 2004 Cialis First Quarter Global Sales of $108 Million; Cialis Surpasses Levitra in New and Total U.S. Prescriptions; Cialis ......
  • Molina Healthcare moves operation to bigger space
  • Molina Healthcare of Washington Inc. , a Bothell, Wash-based health maintenance organization, moved its Spokane office last weekend to a larger space it's leasing at ......
  • Chemex Pharmaceuticals makes announcement.
  • FORT LEE, N.J.--(BUSINESS WIRE)--June 8, 1995--Chemex Pharmaceuticals Inc. announced today that the company has exercised its option to sell its share of rights to Amlexanox, ......
  • To Soothe Canker Sores
  • HEADNOTE WHAT TO DO These red sores with white or yellow centers aren't dangerous, but they can be painful. They may show up inside your ......
  • Chemex announces delay in NDA acceptance with no...
  • FORT LEE, N.J.--(BUSINESS WIRE)--Nov. 17, 1994--Chemex Pharmaceuticals Inc. (NASDAQ:CHMX) on behalf of its joint venture with Block Drug Co., announced today that it has been ......
  • Chemex announces dissolution of joint venture with...
  • FORT LEE, N.J.--(BUSINESS WIRE)--Chemex Pharmaceuticals Inc. (NASDAQ:CHMX), announced today that Chemex and the Block Drug Co. have mutually agreed to dissolve their joint venture in ......
  • Company Profile for American Bioceuticals.
  • In January 2007 American Bioceuticals[TM] launched its first four over-the-counter (OTC) medicines - Lipreve[TM] for cold sores, Orul[TM] for canker sores, Zostamine[TM] for shingles and ......
  • Chemex Reports 1994 Financial Results.
  • FORT LEE, N.J.--(BUSINESS WIRE)--March 23, 1995--Chemex Pharmaceuticals Inc. (NASDAQ:CHMX) reported today financial results for the quarter and year ended December 31, 1994. For the fourth ......
  • Dentistry goes digital with use of new...
  • When patients arrive at Huntington Bay Dental to see Dr. Eugene L. Antenucci, they're likely to experience the sound of silence as dental lasers in ......
  • Chemex announces re-submission of NDA for canker...
  • FORT LEE, N.J.--(BUSINESS WIRE)--April 20, 1995--Chemex Pharmaceuticals Inc. (NASDAQ:CHMX) and the Block Drug Co. Inc. ("Block") announced today that they have re-filed the New Drug ......
  • Access Pharmaceuticals, Inc. Announces Filing...
  • DALLAS--(BW Healthwire)--Aug. 18, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS) today announced that the product license application for amlexanox 5% paste for the treatment of canker sores ......
  • Access Pharmaceuticals Inc. Agrees to...
  • DALLAS--(BW Healthwire)--Oct. 2, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS) today announced that it has signed a Letter of Intent to license amlexanox 5% paste to Meda ......
  • Access Pharmaceuticals, Inc. Announces Filing...
  • DALLAS--(BW Healthwire)--Aug. 18, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS) today announced that the product license application for amlexanox 5% paste for the treatment of canker sores ......
  • EPIEN Medical Distributor Galpharm...
  • MINNEAPOLIS -- EPIEN Medical, Inc., ("EPIEN") announced today that the company's United Kingdom distributor Galpharm International Ltd. ("Galpharm") has signed an agreement with the ......
Find great franshise opportunities that fit your budget. Start your search today!
Industry Type:
Area of Interest:
Liquid Capital: